Eledon Pharmaceuticals, Inc. (ELDN) Total Assets by Year
Eledon Pharmaceuticals, Inc. closed fiscal year 2025 with $169.0M in total assets, $87.9M in total liabilities and $81.1M in shareholder equity. Total assets fell 4.7% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Eledon Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ELDN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K/A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $169.0M-4.7% | $177.4M+99.2% | $89.1M-4.0% | $92.8M-45.6% | $170.5M-13.5% | $197.2M+1703.9% | $10.9M-35.8% | $17.0M-18.5% | $20.9M+1646.8% | $1.2M-98.2% | $68.0M-36.9% | $107.7M+233.7% | $32.3M | N/A |
| Total Liabilities | $87.9M-23.5% | $115.0M-16.4% | $137.6M+99.3% | $69.0M+953.0% | $6.6M-0.5% | $6.6M+349.5% | $1.5M-42.1% | $2.5M+76.0% | $1.4M-63.1% | $3.9M-94.0% | $65.2M+1436.5% | $4.2M-95.2% | $87.6M | N/A |
| Total Equity | $81.1M+29.8% | $62.4Mn/m | -$48.5M-303.8% | $23.8M-85.5% | $164.0M-14.0% | $190.6M+1913.7% | $9.5M-34.7% | $14.5M-25.5% | $19.5Mn/m | -$2.7M-197.1% | $2.8M-97.3% | $103.5Mn/m | -$55.3Mn/m | -$39.9M |
ELDN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K/A | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $126.1M-13.0% | $146.7M-9.1% | $169.0M-4.7% | $129.9M+13.3% | $144.9M+20.3% | $161.3M+99.6% | $177.4M+99.2% | $114.6M+19.3% | $120.5M+12.8% | $80.8M-1.8% | $89.1M-4.0% | $96.1M-35.8% |
| Total Liabilities | $93.1M-1.6% | $101.9M-0.5% | $87.9M-23.5% | $94.5M+0.3% | $94.6M-48.8% | $102.4M-32.3% | $115.0M-16.4% | $94.2M+55.8% | $184.7M+193.1% | $151.2M+1912.8% | $137.6M+99.3% | $60.5M+612.0% |
| Total Equity | $33.0M-34.4% | $44.8M-24.0% | $81.1M+29.8% | $35.4M+73.6% | $50.3Mn/m | $58.9Mn/m | $62.4Mn/m | $20.4M-42.8% | -$64.2M-246.7% | -$70.4M-194.2% | -$48.5M-303.8% | $35.6M-74.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Eledon Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Eledon Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Eledon Pharmaceuticals, Inc. closed fiscal year 2025 with $169.0M in total assets, $87.9M in total liabilities and $81.1M in shareholder equity.
How fast is Eledon Pharmaceuticals, Inc.'s total assets growing?
Eledon Pharmaceuticals, Inc. (ELDN) total assets fell by 4.7% year over year, from $177.4M to $169.0M in fiscal year 2025.
What was Eledon Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Eledon Pharmaceuticals, Inc. (ELDN) reported $126.1M in total assets in Q2 2026. This represents a decrease of 13.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Eledon Pharmaceuticals, Inc. (ELDN) reported on that line in every period on record.